View Older Stories
-
Philip Morris International (PM) Reports In-line EPS, Beats on Revenue; Offers FY26 EPS Guidance
-
Philip Morris International (PM) fourth quarter earnings preview
-
Philip Morris seeks FDA approval for reduced-risk claim on ZYN pouches
-
Jefferies Downgrades Philip Morris (PM) to Hold
-
Philip Morris (PM) Reiterated at Neutral by UBS: Might Miss 2026 Mid-term Targets
-
Increasing unusual option volume: PM MDT DVA ZSL FANG LW OMER NOW CAR RCL
-
Philip Morris International (PM) Declares $1.47 Quarterly Dividend; 3.9% Yield
-
Philip Morris International secures $2 billion credit facility
-
Bernstein's U.S. Consumer Strategy - 'Should We Prepare for a Positive Sector Rotation?'
-
Philip Morris expands Ferrari partnership to feature ZYN branding
-
Philip Morris reaffirms 2025 earnings forecast of $7.39-$7.49 per share
-
Philip Morris restructures into U.S. and international units
-
British American Tobacco Postpones Plan To Launch Unlicensed Vape In US, Reynolds Spokesperson Says - Reuters
-
Stifel Reiterates Philip Morris (PM) at Buy, Says PMI Topline, EPS Growth Profile Favourable to Peers
-
Goldman Sachs Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Lowered to $175 at Morgan Stanley
-
Philip Morris International (PM) call put ratio 1.1 calls to 1 put as share price down 4.4%
-
Stifel on Philip Morris (PM): 'We view the pullback in the shares as an attractive buying point'
-
Philip Morris International (PM) Tops Q3 EPS by 15c, Beats on Revenue
-
Philip Morris earnings preview Q3: strong print expected amid Zyn momentum
-
Philip Morris International seeks FDA panel support for IQOS renewal
-
Philip Morris invests $37 million in Wilson NC manufacturing facility
-
Philip Morris International (PM) Raises Quarterly Dividend 8.9% to $1.47; 3.6% Yield
-
Philip Morris (PM) PT Lowered to $166 at UBS
-
Citi Adjust Catalyst Call List
-
Philip Morris reaffirms 2025 earnings guidance at investor conference
-
Aon plc (AON) Added to Goldman Director's Cut US Conviction List
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris International (PM) Tops Q2 EPS by 5c, Misses on Revenue; offers FY25 EPS Guidance
-
Philp Morris earnings preview Q2: stronger print expected on smoke-free portfolio gains
-
Philip Morris (PM) PT Raised to $200 at Goldman Sachs
-
Philip Morris (PM) PT Raised to $181 at UBS
-
Philip Morris (PM) PT Raised to $200 at Citi
-
Jefferies Starts Philip Morris (PM) at Buy
-
BofA's momentum indicator lists top-ranked stocks globally
-
Goldman rolls out latest U.S. Conviction List update
-
Stifel on Philip Morris (PM): 'We come away from the meetings with a positive bias toward PMI’s developing multi-category approach'
-
Philip Morris International (PM) Declares $1.35 Quarterly Dividend; 2.9% Yield
-
UBS Reiterates Neutral Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Raised to $200 at BofA Securities
-
Philip Morris International (PM) reaffirms its 2025 full-year reported diluted EPS forecast
-
What stocks and implied dividends may indicate when it comes to recession risk
-
UBS upgrades Philip Morris on margin improvement at Zyn and IQOS
-
UBS Upgrades Philip Morris (PM) to Neutral
-
Philip Morris (PM) PT Raised to $186 at Stifel
-
Philip Morris International (PM) Tops Q1 EPS by 9c, Beats on Revenue
-
Philip Morris International (PM) call put ratio 3.7 calls to 1 put with a focus on May 165 calls into quarter results
-
Philip Morris International (PM) call put ratio 1.8 calls to 1 put into quarter results
-
Philip Morris (PM) PT Raised to $130 at UBS

